| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0072-9752(10)97021-8 |
| P698 | PubMed publication ID | 20816427 |
| P50 | author | Maria Gabriella Buzzi | Q60813071 |
| P2093 | author name string | Michael A Moskowitz | |
| P2860 | cites work | Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2 | Q24293004 |
| Mechanisms of migraine aura revealed by functional MRI in human visual cortex | Q24635174 | ||
| Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology | Q28138991 | ||
| Advances in pharmacological treatment of migraine | Q28192002 | ||
| Pediatric migraine equivalents: occurrence and clinical features in practice | Q28203756 | ||
| A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression | Q28248603 | ||
| Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine | Q28264653 | ||
| Vasoactive peptide release in the extracerebral circulation of humans during migraine headache | Q28265001 | ||
| Familial basilar migraine associated with a new mutation in the ATP1A2 gene | Q28286457 | ||
| Suppression of cortical spreading depression in migraine prophylaxis | Q28294907 | ||
| Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4 | Q28295213 | ||
| Influence of beta-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol | Q28343860 | ||
| Pharmacogenomics: translating functional genomics into rational therapeutics | Q33751829 | ||
| Cortical spreading depression activates and upregulates MMP-9. | Q33785624 | ||
| The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine | Q33910986 | ||
| Deconstructing migraine headache into peripheral and central sensitization | Q34134608 | ||
| Triptans | Q34160124 | ||
| Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. | Q34287678 | ||
| Brain stem activation in spontaneous human migraine attacks | Q34297421 | ||
| Correlation between lipophilicity and triptan outcomes | Q34386762 | ||
| A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases | Q34418532 | ||
| The pathophysiology of migraine: year 2005. | Q34476586 | ||
| The global burden of headache: a documentation of headache prevalence and disability worldwide | Q34611721 | ||
| The discovery of a new drug class for the acute treatment of migraine | Q34617817 | ||
| Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials | Q34647375 | ||
| The prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patients | Q34652827 | ||
| Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. | Q34662700 | ||
| Electrophysiological Studies in Migraine: A Comprehensive Review of Their Interest and Limitations | Q35109140 | ||
| Deciphering migraine mechanisms: clues from familial hemiplegic migraine genotypes | Q35645397 | ||
| GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein | Q35755724 | ||
| ??? | Q64763054 | ||
| Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation | Q67535691 | ||
| Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells | Q67823540 | ||
| Ergot alkaloids block neurogenic extravasation in dura mater: proposed action in vascular headaches | Q67997573 | ||
| Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group | Q68241898 | ||
| Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine | Q68265304 | ||
| Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion | Q68271361 | ||
| Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy | Q69968741 | ||
| Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry | Q72728149 | ||
| Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache | Q72827986 | ||
| Guidelines for controlled trials of drugs in migraine: second edition | Q73417055 | ||
| Perfusion-weighted imaging defects during spontaneous migrainous aura | Q74122035 | ||
| Cornea-responsive medullary dorsal horn neurons: modulation by local opioids and projections to thalamus and brain stem | Q74153584 | ||
| Prevention of migraine during prodrome with naratriptan | Q74232197 | ||
| Prognosis of migraine with aura | Q75195637 | ||
| Lifting the burden: The global campaign against headache | Q79814775 | ||
| Prevalence of trigeminal autonomic symptoms in migraine: a population-based study | Q80145691 | ||
| Pharmacogenomics | Q80249601 | ||
| Pathophysiology of migraine | Q83182466 | ||
| The natural course of migraine attacks. A prospective analysis of untreated attacks compared with attacks treated with a triptan | Q83314899 | ||
| Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater | Q35872010 | ||
| The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater | Q35887963 | ||
| Migraine prophylactic drugs work via ion channels | Q36127122 | ||
| The emerging importance of cortical spreading depression in migraine headache. | Q36248844 | ||
| Migraine disease: evolution and progression | Q36260405 | ||
| The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). | Q36261290 | ||
| Association study between clinical response to rizatriptan and some candidate genes | Q36332449 | ||
| Neurophysiological features of the migrainous brain | Q36475091 | ||
| New insights into migraine pathophysiology | Q36479952 | ||
| Migraine: a review and future directions for treatment | Q36546603 | ||
| Migraine in the elderly: a review | Q36719748 | ||
| Potentials and pitfalls in analytical headache epidemiological studies--lessons to be learned from the Head-HUNT study | Q36797316 | ||
| Genetics in primary headaches | Q36847584 | ||
| Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B/1D receptor agonists | Q37357042 | ||
| Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug actions | Q37748431 | ||
| Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders. | Q39355111 | ||
| Triptan nonresponder studies: implications for clinical practice | Q39370824 | ||
| Sumatriptan in migraine with unilateral cranial autonomic symptoms: an open study | Q39396690 | ||
| Cluster headache attacks treated for up to three months with subcutaneous sumatriptan (6 mg). Sumatriptan Cluster Headache Long-term Study Group | Q39474657 | ||
| Cluster headache: evidence for a pathophysiologic focus in the superior pericarotid cavernous sinus plexus | Q39575342 | ||
| Cortical inhibition is reduced in chronic and episodic migraine and demonstrates a spectrum of illness | Q40414417 | ||
| Experimental cranial pain elicited by capsaicin: a PET study | Q42544243 | ||
| Is patent foramen ovale closure effective in reducing migraine symptoms? A controlled study | Q42612004 | ||
| Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model | Q43873034 | ||
| Unilateral cranial autonomic symptoms in migraine. | Q44051813 | ||
| Eletriptan metabolism by human hepatic CYP450 enzymes and transport by human P-glycoprotein | Q44483226 | ||
| No effect of eletriptan administration during the aura phase of migraine | Q45094141 | ||
| Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain | Q46211367 | ||
| Five-year experience with percutaneous closure of patent foramen ovale | Q46811271 | ||
| Premonitory symptoms in migraine: an electronic diary study | Q48015914 | ||
| Magnetic resonance imaging of propagating waves of spreading depression in the anaesthetised rat. | Q48198640 | ||
| Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space | Q48448907 | ||
| Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons | Q48490006 | ||
| Prognosis of migraine and tension-type headache: a population-based follow-up study | Q48538708 | ||
| The neurobiology of vascular head pain | Q48641194 | ||
| Regional cerebral blood flow during migraine attacks by Xenon-133 inhalation and emission tomography. | Q48661735 | ||
| Changes in regional cerebral blood flow during the course of classic migraine attacks | Q48796838 | ||
| Evolution of migraine diagnoses in adolescents: a 3-year annual survey. | Q50759959 | ||
| Migraine in the elderly: a comparison with migraine in young adults. | Q53259772 | ||
| Focal hyperemia followed by spreading oligemia and impaired activation of rcbf in classic migraine | Q57025417 | ||
| P304 | page(s) | 253-266 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn | Q26842295 |
| P1476 | title | Migraine general aspects | |
| P478 | volume | 97 |
| Q41907795 | Effects of LPS on P2X3 receptors of trigeminal sensory neurons and macrophages from mice expressing the R192Q Cacna1a gene mutation of familial hemiplegic migraine-1 |
| Q36217965 | Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega-3 plasma concentrations are altered by treatment |
| Q47234403 | Metabolomics Strategy Using High Resolution Mass Spectrometry Reveals Novel Biomarkers and Pain-Relief Effect of Traditional Chinese Medicine Prescription Wu-Zhu-Yu Decoction Acting on Headache Modelling Rats |
| Q38804214 | Reconsidering Dietary Polyunsaturated Fatty Acids in Bipolar Disorder: A Translational Picture |
| Q34663914 | The mechanism of functional up-regulation of P2X3 receptors of trigeminal sensory neurons in a genetic mouse model of familial hemiplegic migraine type 1 (FHM-1). |
Search more.